Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADAGRASIB for K-ras gene mutation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where ADAGRASIB was used for K-ras gene mutation.

Most Reported Side Effects for ADAGRASIB

Side Effect Reports % Deaths Hosp.
Death 272 30.3% 258 21
Diarrhoea 113 12.6% 9 46
Hospitalisation 108 12.0% 7 108
Nausea 87 9.7% 13 47
Vomiting 79 8.8% 11 44
Off label use 70 7.8% 12 27
Asthenia 61 6.8% 10 39
Fatigue 51 5.7% 4 21
Decreased appetite 43 4.8% 4 20
Dehydration 35 3.9% 3 25
Dyspnoea 32 3.6% 7 18
Dizziness 27 3.0% 3 16
Acute kidney injury 26 2.9% 6 19
Weight decreased 24 2.7% 7 12
General physical health deterioration 19 2.1% 7 12

Other Indications for ADAGRASIB

Lung neoplasm malignant (388) Product used for unknown indication (189) Non-small cell lung cancer (92) Lung adenocarcinoma (42) Colon cancer (41) Lung adenocarcinoma stage iv (20) Non-small cell lung cancer metastatic (15) Bronchial carcinoma (13) Colorectal cancer (11) Colorectal cancer metastatic (9)

Other Drugs Used for K-ras gene mutation

SOTORASIB (752) AMG-510 (173) IRINOTECAN (40) PANITUMUMAB (36) CETUXIMAB (29) PEMBROLIZUMAB (28) BEVACIZUMAB (19) DALOTUZUMAB (18) CARBOPLATIN (17) FLUOROURACIL (17)

Related Pages

ADAGRASIB Full Profile All K-ras gene mutation Drugs ADAGRASIB Demographics ADAGRASIB Timeline